The most important financial indicators for the company Advanced Reserch In Dermatology Srl - Unique Identification Number 30885583:
sales in 2023 was
170.416
euro, registering a net profit of
71.799
euro and having an average number of
2
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 36.8%, from 124.948 euro in the year 2022, to 170.416 euro in 2023.
The Net Profit increased by 25.925 euro, from 46.014 euro in 2022, to 71.799 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Advanced Reserch In Dermatology Srl - CUI 30885583
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
149.275
134.582
113.316
91.842
78.345
58.427
37.772
17.821
16.819
15.714
Current Assets
34.109
1.569
1.574
5.517
7.542
7.448
14.675
23.849
56.985
83.476
Inventories
0
468
402
495
6.673
908
771
5.250
877
1.643
Receivables
33.602
0
0
2.208
163
4.120
2.497
1.083
41.940
66.824
Cash
508
1.101
1.172
2.813
706
2.420
11.407
17.515
14.169
15.010
Shareholders Funds
45
167
2.821
11.868
11.907
29.345
32.511
32.944
46.062
71.848
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
59.326
35.551
112.068
26.878
35.641
17.758
19.937
8.726
27.742
27.342
Income in Advance
124.014
100.433
79.515
58.613
38.340
18.771
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
83.476 euro in 2023 which includes Inventories of
1.643 euro, Receivables of
66.824 euro and cash availability of
15.010 euro.
The company's Equity was valued at
71.848 euro, while total Liabilities amounted to
27.342 euro.
Equity increased by 25.925 euro, from 46.062 euro in 2022, to 71.848 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Advanced Reserch In Dermatology Srl